These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38308252)

  • 21. Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
    Afful P; Vechey GA; Leta PK; Gbafu FB; Aku FY
    PLoS One; 2023; 18(11):e0294928. PubMed ID: 38019801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.
    Chanda E
    BMC Infect Dis; 2024 Apr; 24(1):364. PubMed ID: 38556907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine.
    Pedersen OS; Butova T; Kapustnyk V; Miasoiedov V; Kuzhko M; Hryshchuk L; Kornaha S; Borovok N; Raznatovska O; Fedorec A; Bogomolov A; Tkhorovskiy M; Akymenko O; Klymenko I; Kulykova O; Karpenko Z; Shapoval T; Chursina N; Kondratyuk N; Parkhomenko O; Sazonenko I; Ostrovskyy M; Makoida I; Markovtsiy L; Skryp V; Lubenko V; Hrankina N; Bondarenko L; Hlynenko V; Dahl VN; Butov D
    Clin Microbiol Infect; 2024 Mar; 30(3):360-367. PubMed ID: 38065363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting time to treatment initiation after diagnosis for multidrug-resistant/rifampicin-resistant tuberculosis patients: A mixed-methods study in Jakarta, Indonesia.
    Silitonga P; Jiang W; Wyatt S; Burhan E; Kes EFM; Long Q
    Trop Med Int Health; 2023 Jan; 28(1):43-52. PubMed ID: 36477995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
    Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
    BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.
    Dan-Ni Z; Guang-Min Z; Yu-Hua D; Ying L; Ting W; Yuan-Yuan C; Yu-Hong X; Xin-Cai X
    Front Public Health; 2024; 12():1372389. PubMed ID: 38601494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.
    Ahuja SD; Ashkin D; Avendano M; Banerjee R; Bauer M; Bayona JN; Becerra MC; Benedetti A; Burgos M; Centis R; Chan ED; Chiang CY; Cox H; D'Ambrosio L; DeRiemer K; Dung NH; Enarson D; Falzon D; Flanagan K; Flood J; Garcia-Garcia ML; Gandhi N; Granich RM; Hollm-Delgado MG; Holtz TH; Iseman MD; Jarlsberg LG; Keshavjee S; Kim HR; Koh WJ; Lancaster J; Lange C; de Lange WC; Leimane V; Leung CC; Li J; Menzies D; Migliori GB; Mishustin SP; Mitnick CD; Narita M; O'Riordan P; Pai M; Palmero D; Park SK; Pasvol G; Peña J; Pérez-Guzmán C; Quelapio MI; Ponce-de-Leon A; Riekstina V; Robert J; Royce S; Schaaf HS; Seung KJ; Shah L; Shim TS; Shin SS; Shiraishi Y; Sifuentes-Osornio J; Sotgiu G; Strand MJ; Tabarsi P; Tupasi TE; van Altena R; Van der Walt M; Van der Werf TS; Vargas MH; Viiklepp P; Westenhouse J; Yew WW; Yim JJ;
    PLoS Med; 2012; 9(8):e1001300. PubMed ID: 22952439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
    Suryavanshi N; Murrill M; Gupta A; Hughes M; Hesseling A; Kim S; Naini L; Jones L; Smith B; Gupte N; Dawson R; Mave V; Meshram S; Mendoza-Ticona A; Sanchez J; Kumarasamy N; Comins K; Conradie F; Shenje J; Nerette Fontain S; Garcia-Prats A; Asmelash A; Nedsuwan S; Mohapi L; Lalloo U; Cristina Garcia Ferreira A; Okeyo E; Swindells S; Churchyard G; Shah NS
    Clin Infect Dis; 2020 Jan; 70(3):436-445. PubMed ID: 30919881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus.
    Marks SM; Magee E; Robison V
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):465-70. PubMed ID: 21396204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital.
    Omona K; Opiyo AM
    Afr Health Sci; 2023 Sep; 23(3):343-357. PubMed ID: 38357137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citywide Transmission of Multidrug-resistant Tuberculosis Under China's Rapid Urbanization: A Retrospective Population-based Genomic Spatial Epidemiological Study.
    Jiang Q; Liu Q; Ji L; Li J; Zeng Y; Meng L; Luo G; Yang C; Takiff HE; Yang Z; Tan W; Yu W; Gao Q
    Clin Infect Dis; 2020 Jun; 71(1):142-151. PubMed ID: 31504306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.
    Nellums LB; Rustage K; Hargreaves S; Friedland JS
    BMC Med; 2018 Feb; 16(1):27. PubMed ID: 29466983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
    Mpagama SG; Ezekiel MJ; Mbelele PM; Chongolo AM; Kibiki GS; de Guex KP; Heysell SK
    BMC Public Health; 2020 Nov; 20(1):1667. PubMed ID: 33160327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa.
    Lotz JK; Porter J; Conradie H; Boyles T; Gaunt B; Dimanda S; Cort D
    S Afr Med J; 2023 Nov; 113(11):47-56. PubMed ID: 38525642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China.
    Sun Y; Harley D; Vally H; Sleigh A
    BMC Public Health; 2015 Oct; 15():1027. PubMed ID: 26444417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis on time delay of tuberculosis among adolescents and young adults in Eastern China.
    Ge R; Zhu G; Tian M; Hou Z; Pan W; Feng H; Liu K; Xiao Q; Chen Z
    Front Public Health; 2024; 12():1376404. PubMed ID: 38651131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in South Africa.
    Tomita A; Ramlall S; Naidu T; Mthembu SS; Padayatchi N; Burns JK
    Soc Psychiatry Psychiatr Epidemiol; 2019 Mar; 54(3):387-393. PubMed ID: 30758540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China.
    Zhao JN; Zhang XX; He XC; Yang GR; Zhang XQ; Xin WG; Li HC
    PLoS One; 2015; 10(8):e0135205. PubMed ID: 26284920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review.
    Harris RC; Grandjean L; Martin LJ; Miller AJ; Nkang JE; Allen V; Khan MS; Fielding K; Moore DA
    BMC Infect Dis; 2016 May; 16():193. PubMed ID: 27142682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influencing factors of death in patients with MDR-TB based on Bayesian Cox regression model.
    Wang Z; Zhang Y; Gao W; Li Z; Li M; Luo Q; Xiang Y; Bao K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1659-1668. PubMed ID: 38432856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.